Literature DB >> 3087921

An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

J J Neefjes, B S Breur-Vriesendorp, G A van Seventer, P Iványi, H L Ploegh.   

Abstract

A simple method is described for the biochemical analysis of HLA class I antigens. It is a modification of a previously published procedure for one-dimensional isoelectric focusing (1D-IEF), giving improved resolution and offering larger sample capacity. One million viable cells suffice for analysis, and no more than 25 muCi of radioisotope (35S-methionine) are required. The usefulness of the method is illustrated by the characterization of a total of four biochemically distinct subtypes of HLA-B27, three subtypes of HLA-A24, two subtypes of HLA-A11, three subtypes of HLA-A2, two subtypes of HLA-Bw60, two subtypes of HLA-Bw62, and four subtypes of HLA-B35 in a panel of 24 cells selected for the expression of HLA-B27. We envision that this technique will allow a rigorous classification of HLA-A,B antigens into novel subtypes. Populations of distinct ethnic origin are especially of interest in this regard. This technique might also be used as an additional criterion for the official classification of HLA-A,B antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087921     DOI: 10.1016/0198-8859(86)90046-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  41 in total

Review 1.  Paediatric bone marrow transplantation using donors other than HLA genotypically identical siblings.

Authors:  J M Hows
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Molecular typing of HLA-B27 alleles.

Authors:  O Dominguez; E Coto; E Martinez-Naves; S Y Choo; C López-Larrea
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.

Authors:  A M Little; J A Madrigal; P Parham
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.

Authors:  R Khanna; S R Burrows; A Neisig; J Neefjes; D J Moss; S L Silins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.

Authors:  B S Breur-Vriesendorp; A J Dekker-Saeys; P Ivanyi
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

6.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.

Authors:  M F Kleijnen; J B Huppa; P Lucin; S Mukherjee; H Farrell; A E Campbell; U H Koszinowski; A B Hill; H L Ploegh
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

7.  Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain.

Authors:  A Hill; M Takiguchi; A McMichael
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  A primate species with limited major histocompatibility complex class I polymorphism.

Authors:  D I Watkins; F S Hodi; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  HLA-C "blank" alleles express class I gene products. Biochemical analysis of four different HLA-C "blank" polypeptides.

Authors:  A Hajek-Rosenmayr; L Jungl; M Stammler; M Kirnbauer
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

10.  Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas.

Authors:  Z Végh; P Wang; F Vánky; C Hising; K Sjöwall; B Larsson; E Klein
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.